Thus, it has been reported that miRNA-145, which is aberrantly methylated in various cancers, negatively regulates the expression of ADAM17 in renal and hepatocellular carcinomas [43, 44]. The gene discussed is ADAM17; the disease is hepatocellular carcinoma.